Metastatic Renal Cell Carcinoma Completed Phase 1 / 2 Trials for Aldesleukin (DB00041)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01550367Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)Treatment
NCT00414765Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic MelanomaTreatment